We performed cumulative meta-analysis to determine the role of AFAP1-AS1 in disease-free survival (DFS) of 244 cancer patients [19, 25, 31] and progression-free survival (PFS) of 252 cancer patients [28, 30] from the eligible studies (Figure 3). This evidence concerns the gene AFAP1 and cancer.